Skip to main content

Table 1 Clinical and pathological characteristics of patients with DLBCL in our study

From: An integrated prognosis model of pharmacogenomic gene signature and clinical information for diffuse large B-cell lymphoma patients following CHOP-like chemotherapy

Characteristic

Training dataset

Validating dataset

(GSE31312)

(GSE10846)

Sample size

449

342

Age, years mean (SD)

61.81 (14.75)

61.24 (15.48)

Gender

 Female

189

144

 Male

260

182

 Unknown

0

16

Stage

 1

124

58

 2

96

103

 3

101

77

 4

128

104

 Unknown

0

0

 ≥ 2 Extranodal sites

100

29

 ECOGa performance status > 1

81

84

Microarray subtype

 GCB

214

147

 ABC

193

144

 Unclassified subtype

42

51

 Unknown

0

0

Overall survival

 Time, years mean (SD)

3.24 (2.14)

2.80 (2.35)

 Death

164

148

  1. GCB germinal center B-cell-like subtype, ABC activated B-cell-like subtype, SD standard deviation
  2. aThe Eastern Cooperative Oncology Group (ECOG) performance score ranges from 0 to 3, with a higher score indicating greater impairment